Calypso Medical Technologies, Inc. is a Seattle-based privately held medical device company. Calypso Medical addresses two major issues in modern radiation oncology: errors in treatment set-up and management of tumor motion during treatment. The technology is designed for body-wide cancers commonly treated with radiation therapy. The products are FDA 510(k) cleared for use in the prostate and post-operative prostatic bed.